Dare Bioscience Inc (DARE) — Strategic Asset Allocation Index
Dare Bioscience Inc (DARE) has a Strategic Asset Allocation Index of 1.1% as of March 2023. Strategic assets (PP&E of $55.40K plus long-term investments of $-) total $55.40K, measured against net assets of $4.97 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Dare Bioscience Inc Strategic Asset Allocation Index (2014–2021)
This chart shows how Dare Bioscience Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2014 to 2021. As of March 2023, the index stands at 1.1%, representing strategic assets of $55.40K against net assets of $4.97 Million USD. Explore cash efficiency ratio of Dare Bioscience Inc to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Dare Bioscience Inc (2014–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Dare Bioscience Inc from 2014 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Dare Bioscience Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.6% | $242.71K | $242.71K | $- | $38.75 Million | ▼ -13.8 pp |
| 2019 | 14.4% | $63.53K | $63.53K | $- | $440.83K | ▲ +14.3 pp |
| 2018 | 0.1% | $9.40K | $9.40K | $- | $6.73 Million | ▲ +0.1 pp |
| 2017 | 0.0% | $0.00 | $0.00 | $- | $13.29 Million | ▼ -5.1 pp |
| 2016 | 5.1% | $668.00K | $668.00K | $- | $13.11 Million | ▲ +3.9 pp |
| 2015 | 1.2% | $576.00K | $576.00K | $- | $48.74 Million | ▲ +0.4 pp |
| 2014 | 0.8% | $342.00K | $342.00K | $0.00 | $45.33 Million | — |